Xenon Pharmaceuticals (XENE) EPS (Basic) (2013 - 2026)
Xenon Pharmaceuticals (XENE) reported EPS (Basic) of -$1.17 for Q1 2026, down 40.96% year-over-year from -$1.98 in Q1 2025, and up 10.69% quarter-over-quarter from -$1.31 in Q4 2025.
Xenon Pharmaceuticals (XENE) EPS (Basic) (2013 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 14 years of EPS (Basic) data on file, last reported at -$1.17 in Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$1.17, down 40.96% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.7 (down 45.51% YoY), and the FY2025 annual result was -$4.36, down 44.85% from the prior year.
- EPS (Basic) improved to -$1.17 in Q1 2026 per XENE's latest filing, from -$1.31 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.35 in Q1 2022 and troughed at -$1.31 in Q4 2025.
- A 5-year average of -$0.78 and a median of -$0.73 in 2023 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) rose 16.67% in 2022, then sank 80.0% in 2023.
- A 5-year view of EPS (Basic) shows it stood at -$0.57 in 2022, then slipped by 12.28% to -$0.64 in 2023, then plunged by 31.25% to -$0.84 in 2024, then tumbled by 55.95% to -$1.31 in 2025, then climbed by 10.69% to -$1.17 in 2026.
- Business Quant data shows XENE's EPS (Basic) at -$1.17 in Q1 2026, -$1.31 in Q4 2025, and -$1.15 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Xenon Pharmaceuticals | 4.61 Bn | 4.61 Bn | - | -1.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.17 |
| Dec 31, 2025 | -1.31 |
| Sep 30, 2025 | -1.15 |
| Jun 30, 2025 | -1.07 |
| Mar 31, 2025 | -0.83 |
| Dec 31, 2024 | -0.84 |
| Sep 30, 2024 | -0.81 |
| Jun 30, 2024 | -0.75 |
| Mar 31, 2024 | -0.62 |
| Dec 31, 2023 | -0.64 |
| Sep 30, 2023 | -0.73 |
| Jun 30, 2023 | -0.72 |
| Mar 31, 2023 | -0.63 |
| Dec 31, 2022 | -0.57 |
| Sep 30, 2022 | -0.57 |
| Jun 30, 2022 | -0.55 |
| Mar 31, 2022 | -0.35 |
| Dec 31, 2021 | -0.48 |
| Sep 30, 2021 | -0.36 |
| Jun 30, 2021 | -0.51 |